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The influence of race/ethnicity and place of
service on breast reconstruction for Medicare
beneficiaries with mastectomy
Tracy Onega1,2,3*, Julie Weiss1, Karla Kerlikowske4,5, Karen Wernli6, Diana SM Buist6, Louise M Henderson7,
Martha Goodrich1,2, Jennifer Alford-Teaster1,2, Beth Virnig8, Anna NA Tosteson2,3, Wendy DeMartini9
and Rebecca Hubbard6
Abstract
Racial disparities in breast reconstruction for breast cancer are documented. Place of service has contributed to
disparities in cancer care; but the interaction of race/ethnicity and place of service has not been explicitly
examined. We examined whether place of service modified the effect of race/ethnicity on receipt of reconstruction.
We included women with a mastectomy for incident breast cancer in SEER-Medicare from 2005–2009. Using Medicare
claims, we determined breast reconstruction within 6 months. Facility characteristics included: rural/urban location,
teaching status, NCI Cancer Center designation, cooperative oncology group membership, Disproportionate Share
Hospital (DSH) status, and breast surgery volume. Using multivariable logistic regression, we analyzed reconstruction in
relation to minority status and facility characteristics.
Of the 17,958 women, 14.2% were racial/ethnic women of color and a total of 9.3% had reconstruction. Caucasians
disproportionately received care at non-teaching hospitals (53% v. 42%) and did not at Disproportionate Share
Hospitals (77% v. 86%). Women of color had 55% lower odds of reconstruction than Caucasians (OR = 0.45; 95%
CI 0.37-0.55). Those in lower median income areas had lower odds of receiving reconstruction, regardless of race/
ethnicity. Odds of reconstruction reduced at rural, non-teaching and cooperative oncology group hospitals, and
lower surgery volume facilities. Facility effects on odds of reconstruction were similar in analyses stratified by
race/ethnicity status.
Race/ethnicity and facility characteristics have independent effects on utilization of breast reconstruction, with no
significant interaction. This suggests that, regardless of a woman’s race/ethnicity, the place of service influences
the likelihood of reconstruction.
Keywords: Reconstruction; Disparities; Mastectomy; Breast cancer
Introduction
Breast reconstruction following mastectomy for breast
cancer is associated with better quality of life, (Alderman
et al. 2006) lower decisional regret, improved self-image,
and other benefits, relative to mastectomy without re-
construction (Albornoz et al. 2013). In fact, based on
evidence and political will, the 1999 Women’s Health
and Cancer Rights Act (WHCRA) mandated insurance
coverage for breast reconstruction after mastectomy to
try to ensure access (Albornoz et al. 2013). Despite the
WHCRA, and additional legislation in 2001 that im-
posed penalties on insurers for non-coverage, reports of
women of all ages eligible for breast reconstruction re-
ceiving it range from <20% to 60% (Jagsi et al. 2014;
Alderman et al. 2009; Christian et al. 2006; Hershman
et al. 2012). Women of color have been shown to be
significantly less likely to receive breast reconstruction –
for African American women, less than half as likely as
Caucasian women (Alderman et al. 2006; Jagsi et al.
2014; Alderman et al. 2009; Alderman et al. 2003; Bian
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et al. 2008). The reasons underlying this disparity are
not clear, although the disparity may relate to other factors
shown to decrease the likelihood of breast reconstruction,
such as marital status, rural residence, comorbidities, in-
surance, surgeon volume, hospital volume, hospital size,
(Hershman et al. 2012) teaching hospital status, and can-
cer center designation (Kruper et al. 2011a).
Racial disparities may be due in part to where patients
receive care (Morris et al. 2010). For example, a recent
study of women with breast cancer showed that type of
hospital at which women received definitive therapy ex-
plained some of the racial disparities observed in treat-
ment (Keating et al. 2009). Our understanding of how
race/ethnicity and place of service interact to affect
utilization of care and outcomes for cancer is lacking,
but is vital to understanding and developing interven-
tions to reduce disparities. While both race/ethnicity
and facility characteristics have been examined, no stud-
ies to date have explicitly examined the interaction of
race/ethnicity and hospital characteristics on utilization
of breast reconstruction. The objective of this study was
to explicitly examine how Caucasian and women of
color with breast cancer differ in their utilization of breast
reconstruction following mastectomy and whether effects
associated with the types of facilities they use vary for
Caucasian and women of color.
Methods
Data
We used data from the National Cancer Institute’s Surveil-
lance, Epidemiology, and End Results (SEER) program –
linked to Medicare claims (National Cancer Institute
2014). At the time of these analyses, SEER captured inci-
dent cancer cases from 17 population-based registries,
(2014) representing 26% of the U.S. population. SEER re-
cords standardized patient demographic, clinical, and vital
status information in the Patient Entitlement and Diagno-
sis Summary File (PEDSF). Individuals within the SEER
registries are linked to Medicare data from the time of eli-
gibility until death through an algorithm with a 93% match
rate (Warren et al. 2002). This study used Medicare benefi-
ciary information (Denominator File), inpatient data (Med-
PAR), outpatient data (Outpatient Claims), and physician
visit data (Carrier Claims). We also used the Hospital File,
which links to both MedPAR and Outpatient claims files at
the facility level to provide facility characteristics informa-
tion based on the Healthcare Cost Report Information Sys-
tem (HCRIS) and the Provider of Service (POS) Survey
administered through the Centers for Medicaid and Medi-
care Services (CMS) (2014).
Study population
We included age-eligible women in Medicare with an in-
cident breast cancer from 2005–2009 recorded in SEER
(N = 114,454), with claims through 2010. We excluded
women diagnosed upon autopsy (N = 1,619), those who
did not have part A & B coverage (N = 13,174) or had
HMO coverage (N = 28,468) one year before and
6 months after diagnosis. We further excluded women
without pathologic confirmation of breast cancer (N = 786);
reported from a nursing home (N = 10); reported sur-
gery as not recommended (N = 3,029) or contraindi-
cated (N = 205); who died prior to surgery (N = 1); or
who had an unknown reason for surgery (N = 561), re-
fused surgery (N = 434), or reported surgery as recom-
mended but unknown if performed (N = 362). Finally,
we then included the remaining women with early stage
breast cancer (Stages 0, I, and II), non-missing race/
ethnicity, mastectomy within 6 months of diagnosis,
and who had a provider link to the Hospital File, result-
ing in an analytic sample of 17,958 women.
Key variables – exposures, outcome, and covariates
The main exposures of interest in this study were race/
ethnicity and characteristics of the facility at which a
woman’s mastectomy occurred. Race/ethnicity was ascer-
tained through the SEER PEDSF File, as 6 mutually- ex-
clusive categories: Caucasian, African American, Hispanic,
Asian, Native American, and Other. We further catego-
rized race/ethnicity into: 1) women of color (African
American, Hispanic, Asian, Native American, Other); and
2) Caucasian. Facility characteristics included: urban/rural,
teaching hospital, NCI Cancer Center, cooperative oncol-
ogy group member, and Disproportionate Share Hospital
(DSH) – those that provide a certain amount of uncom-
pensated care, (2014) as taken from the Hospital File
linked to the mastectomy facility. In addition, we derived
hospital-level breast cancer surgery volume empirically
based on all mastectomy and breast conserving surgeries
observed in claims from the study period attributed to
unique facilities, and categorized into quartiles (surgery
N – Quartile 1: 1–8; Quartile 2: 9–18; Quartile 3: 19–
35; Quartile 4: 36+).
Our outcome of interest was receipt of breast recon-
struction following mastectomy (which occurred within
6 months of breast cancer diagnosis). We ascertained
breast reconstruction from MedPAR and Outpatient
Files using ICD-9 and CPT/HCPCS codes (Table 1). We
identified breast reconstruction from the date of mastec-
tomy and 6 months thereafter.
We included covariates that we considered a priori to
be potential confounders: age at diagnosis, urban/rural
residence SEER registry, comorbidities, stage at diagnosis
and quartile of median household income for census
tract of residence at time of diagnosis. All of these covar-
iates were taken from the PEDSF, except for comorbidi-
ties, which were derived from the claims file (MedPAR,
Outpatient, and Carrier) using the Klabunde adaptation
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(Klabunde et al. 2000) of the Charlson Index (Charlson
et al. 1987).
Analyses
We conducted descriptive analyses of patient characteris-
tics, and the characteristics of the hospitals at which their
mastectomies were performed, overall and by receipt of
reconstruction. We also stratified facility characteristics
and median income by race/ethnicity to examine their
joint distributions. Multivariable logistic regression models
were used to estimate the odds of reconstruction in rela-
tion to women and facility characteristics. We developed
an overall model for receipt of reconstruction, as well as a
models stratified by Caucasian/women of color. To for-
mally test for interactions between race/ethnicity and
facility characteristics, fully adjusted regression models
were run with each race/ethnicity and facility characteristic
interaction. Statistical power for multivariable modeling
was not adequate to separately model Hispanic, Asian, Na-
tive American, or Other racial/ethnic groups. We therefore
modeled odds of reconstruction for Caucasian and women
of color, including the facility characteristics: teaching hos-
pital, urban/rural location, NCI Cancer Center, member of
one or more cooperative oncology groups, DSH, and
breast cancer surgery volume. Covariates included were:
age in years (66–69, 70–74, 75–79, 80–84, 85+), quartile of
income based on residence, rural/urban residence, SEER
registry, stage at diagnosis, and comorbidities. Sensitivity
analyses included: similar models but only with Caucasians
and African Americans; and forward stepwise logistic re-
gression models, observing changes in the race/ethnicity
point estimate as facility characteristics were added to the
multivariable model. All analyses were conducted using
SAS 9.3 (Cary, NC) and a p-value < 0.05 was considered
statistically significant.
Results
Of the 17,958 women in the cohort, 85.8% were Caucasian,
8.3% were African American, and 6.0% were Asian, Native
American, Hispanic, and Other race/ethnicity combined
(Table 2). Women were distributed relatively evenly across
five-year age groups up to 84 years, with a notably lower
proportion of women over age 85 years (13.1%) (Table 2).
The majority of women had no comorbidities (59.7%), lived
in an urban location (86.1%), and had early stage invasive
cancer (85.9%) (Table 2). Approximately half of the women
attended a teaching hospital or a hospital belonging to one
or more cooperative oncology groups, but only 3.7%
attended an NCI Cancer Center (Table 2). The frequency
of reconstruction was higher among: younger Medicare
beneficiaries, Caucasians, women with an urban residence,
higher income quartile in census tract of residence, those
with DCIS, and no comorbidities (Table 2). Immediate re-
construction (same day as mastectomy) accounted for the
vast majority (>90%) of cases, while the 99th percentile for
time to reconstruction was 160 days.
Examining facility characteristics stratified by racial/eth-
nic groups, African American women were more likely to
receive mastectomies at teaching hospitals, and have more
representation in hospitals with DSH designation than
were other racial/ethnic groups (Table 3). Hispanic and
Native American women were the least represented at fa-
cilities belonging to one or more cooperative oncology
groups and to those with the highest quartile of breast
cancer surgery volume (data not shown).
In multivariable logistic regression models, odds of
breast reconstruction following mastectomy was signifi-
cantly lower for women of color compared to Caucasian
women (OR = 0.45; 95% CI 0.37-0.55), as well as for
lower quartiles of census tract-level median household
income, after adjusting for facility characteristics, SEER
Table 1 Procedure codes used in this analysis
Procedure ICD-9 Procedure Codes CPT Codes DRG Codes Time Interval
Mastectomy 85.3, 85.33-85.36, 85.4,
85.41-85.48, V51.0
19180, 19182, 19200,
19240, 19303-19307
257, 258, 582, 583 Breast cancer diagnosis date + 6 months/
Any mastectomy occurring during diagnosis
years 2005-2009α
Breast
conserving
surgery
85.22, 85.23 19160, 19162, 19301, 19302 259, 260 Any BCS occurring during diagnosis
years 2005-2009α
Reconstruction
Implant 85.33, 85.35, 85.53, 85.54,
85.6, 85.89, 85.93-85.95
19340, 19342 Mastectomy + 6 months
Flap 85.7, 85.70-85.76, 85.79,
85.82-85.85, 85.87, 86.60,
86.70, 86.72, 86.74, 86.75
Mastectomy + 6 months
Tissue Expander 85.96 19357 Mastectomy + 6 months
Autologous 19350, 19361, 19364,
19366-19369
Mastectomy + 6 months
Abbreviations: CPT, current procedural terminology; ICD, International Classification of Diseases; DRG, Diagnosis Related Groups.
αTime frame for calculation of breast surgery volume.
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Table 2 Reconstructionα among early stage breast cancer female Medicare beneficiaries with a mastectomy
(N = 17,958) from 2005-2009
Without reconstruction With reconstruction Total
Women's characteristicsβ N (%) N (%) N (column%)
Total 16,297 (90.7) 1,661 (9.3) 17,958 (100.0)
Age (years)
66-69 2,734 (16.8) 714 (43.0) 3,448 (19.2)
70-74 3,828 (23.5) 574 (34.6) 4,402 (24.5)
75-79 4,062 (24.9) 279 (16.8) 4,341 (24.2)
80-84 3,345 (20.5) 65 (3.9) 3,410 (19.0)
85+ 2,328 (14.3) 29 (1.7) 2,357 (13.1)
Race/ethnicity
Caucasian 13,882 (85.2) 1,522 (91.6) 15,404 (85.8)
African American 1,402 (8.6) 82 (4.9) 1,484 (8.3)
Other τ 1,013 (6.2) 57 (3.4) 1,070 (6.0)
Urban/Rural
Urban 13,909 (85.4) 1,545 (93.0) 15,454 (86.1)
Rural 2,385 (14.6) 116 (7.0) 2,501 (13.9)
Median income
Quartile 4 (> = $59,450) 3,731 (23.1) 717 (43.4) 4,448 (25.0)
Quartile 3 ($44,000-$59,449) 4,020 (24.9) 441 (26.7) 4,461 (25.1)
Quartile 2 ($33,750-43,999) 4,147 (25.7) 283 (17.1) 4,430 (24.9)
Quartile 1 (<$33,750) 4,239 (26.3) 213 (12.9) 4,452 (25.0)
Stage at diagnosis
0 2,331 (14.3) 382 (23.0) 2,713 (15.1)
I 6,959 (42.7) 730 (44.0) 7,689 (42.8)
II 7,007 (43.0) 549 (33.0) 7,556 (42.1)
Comorbidities
0 9,504 (58.3) 1,217 (73.3) 10,721 (59.7)
1 4,204 (25.8) 335 (20.2) 4,539 (25.3)
2+ 2,589 (15.9) 109 (6.6) 2,698 (15.0)
Facility characteristicsβ
Urban/Rural
Urban 13,733 (86.0) 1,596 (97.7) 15,329 (87.1)
Rural 2,239 (14.0) 37 (2.3) 2,276 (12.9)
Teaching hospital
No 8,516 (52.5) 671 (40.6) 9,187 (51.4)
Yes 7,710 (47.5) 981 (59.4) 8,691 (48.6)
NCI cancer center
No 15,765 (96.7) 1,536 (92.5) 17,301 (96.3)
Yes 532 (3.3) 125 (7.5) 657 (3.7)
Cooperative oncology group
No 8,146 (50.0) 535 (32.2) 8,681 (48.3)
Yes 8,151 (50.0) 1,126 (67.8) 9,277 (51.7)
Disproportionate share hospital
No 3,503 (21.7) 448 (27.1) 3,951 (22.2)
Onega et al. SpringerPlus 2014, 3:416 Page 4 of 9
http://www.springerplus.com/content/3/1/416
Table 2 Reconstructionα among early stage breast cancer female Medicare beneficiaries with a mastectomy
(N = 17,958) from 2005-2009 (Continued)
Yes 12,634 (78.3) 1,203 (72.9) 13,837 (77.8)
Breast cancer surgery volume
Quartile 4 (36+) 3,987 (24.6) 687 (41.5) 4,674 (26.1)
Quartile 3 (19-35) 4,129 (25.5) 444 (26.8) 4,576 (25.6)
Quartile 2 (9-18) 4,296 (26.5) 314 (19.0) 4,610 (25.8)
Quartile 1 (1-8) 3,815 (23.5) 210 (12.7) 4,025 (22.5)
αReconstruction within 6 months of mastectomy.
βMissing (N): Women's Urban/Rural (3); Median Income (167); Facility's Urban/Rural (353); Teaching Hospital (80); Disproportionate Share Hospital (170);
Breast Cancer Surgery Volume (76).
τOther includes Hispanic, Asian, Native American and Other.
Table 3 Women's census tract median income and facility characteristics by race/ethnicity among early stage breast
cancer female Medicare beneficiaries with a mastectomy (N = 17,958) from 2005-2009
Caucasian (N = 15,404) African American (N = 1,484) Otherβ (N = 1,070)
Women's characteristics N (column%)
Median income
Quartile 4 (> = $59,450) 3,953 (25.9) 134 (9.1) 361 (34.0)
Quartile 3 ($44,000-$59,449) 3,962 (26.0) 221 (15.0) 278 (26.2)
Quartile 2 ($33,750-43,999) 3,917 (25.7) 306 (20.7) 207 (19.5)
Quartile 1 (<$33,750) 3,422 (22.4) 815 (55.2) 215 (20.3)
Facility characteristicsα
Urban/Rural
Urban 13,038 (86.4) 1,303 (89.3) 988 (94.1)
Rural 2058 (13.6) 156 (10.7) 62 (5.9)
Teaching hospital
No 8,115 (52.9) 574 (38.8) 498 (46.9)
Yes 7,223 (47.1) 905 (61.2) 563 (53.1)
NCI cancer center
No 14,858 (96.5) 1,433 (96.6) 1,010 (94.4)
Yes 546 (3.5) 51 (3.4) 60 (5.6)
Cooperative oncology group
No 7,386 (48.0) 759 (51.2) 536 (50.1)
Yes 8,018 (52.0) 725 (48.8) 534 (49.9)
Disproportionate share hospital
No 3,629 (23.8) 173 (11.7) 149 (14.1)
Yes 11,620 (76.2) 1,306 (88.3) 911 (85.9)
Breast cancer surgery volume
Quartile 4 (36+) 4,070 (26.5) 376 (25.4) 228 (21.4)
Quartile 3 (19-35) 4,009 (26.1) 323 (21.8) 241 (22.7)
Quartile 2 (9-18) 3,930 (25.6) 393 (26.6) 287 (27.0)
Quartile 1 (1-8) 3,329 (21.7) 388 (26.2) 308 (29.0)
αMissing (N): Median Income (167); Facility's Urban/Rural (353); Teaching Hospital (80); Disproportionate Share Hospital (170); Breast Cancer Surgery Volume (76).
βOther includes Hispanic, Asian, Native American and Other.
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registry, age, rural/urban status, cancer stage, and co-
morbidity score (Table 4). Odds of reconstruction varied
widely among the 16 SEER registries compared to the
Greater California SEER registry ranging from more
likely to receive reconstruction in Hawaii (OR = 4.07;
95% CI 1.46-11.33) to less likely in Los Angeles (OR =
0.51; 95% CI 0.41-0.64) (Figure 1). Several facility char-
acteristics were also associated with lower odds of breast
reconstruction, including: rural (OR = 0.33; 95% CI 0.23-
0.48 relative to urban), a non-teaching hospital (OR =
0.75; 95% CI 0.65-0.85), not a cooperative oncology
group member (OR = 0.68; 95% CI 0.59-0.77), and lower
breast cancer surgery volume (Table 4). Estimates for fa-
cility characteristics were similar for Caucasian and
women of color, in the stratified models, indicating that
race/ethnicity does not modify associations between fa-
cility characteristics or median household income and
receipt of reconstruction. No statistically significant in-
teractions between race/ethnicity and any of the facility
characteristics or median income were found when
interaction terms for women of color status or median
income with each facility characteristics were entered
Table 4 Odds ratiosα and 95% confidence intervals for reconstruction within 6 months of a mastectomy among female
Medicare beneficiaries with early stage breast cancer from 2005-2009 overall and stratified by race/ethnicity
Reconstruction within 6 Months
All Women Caucasian Women of colorβ
Women's characteristics OR (95% CI)α
Race/ethnicity
Caucasian (N = 15,404) 1.00 (referent)
Women of color (N = 2,554) 0.45 (0.37-0.55)
Median income p for trend <0.0001 p for trend <0.0001 p for trend =0.08
Quartile 4 (> = $59,450) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 3 ($44,000-$59,449) 0.73 (0.63-0.84) 0.72 (0.62-0.84) 0.78 (0.47-1.29)
Quartile 2 ($33,750-43,999) 0.54 (0.45-0.64) 0.53 (0.44-0.64) 0.52 (0.30-0.91)
Quartile 1 (<$33,750) 0.45 (0.37-0.55) 0.45 (0.36-0.56) 0.39 (0.22-0.69)
Facility characteristics
Urban/Rural
Urban 1.00 (referent) 1.00 (referent) 1.00 (referent)
Rural 0.33 (0.23-0.48) 0.34 (0.23-0.49) 0.24 (0.05-1.09)
Teaching hospital
No 0.75 (0.66-0.85) 0.74 (0.65-0.85) 0.76 (0.49-1.17)
Yes 1.00 (referent) 1.00 (referent) 1.00 (referent)
NCI cancer center
No 0.86 (0.68-1.09) 0.83 (0.65-1.06) 1.42 (0.64-3.16)
Yes 1.00 (referent) 1.00 (referent) 1.00 (referent)
Cooperative oncology group
No 0.68 (0.59-0.77) 0.69 (0.60-0.79) 0.57 (0.36-0.90)
Yes 1.00 (referent) 1.00 (referent) 1.00 (referent)
Disproportionate share hospital
No 1.00 (referent) 1.00 (referent) 1.00 (referent)
Yes 0.89 (0.78-1.02) 0.90 (0.78-1.04) 0.75 (0.45-1.27)
Breast cancer surgery volume p for trend <0.0001 p for trend <0.0001 p for trend =0.41
Quartile 4 (36+) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 3 (19-35) 0.76 (0.66-0.87) 0.75 (0.64-0.87) 0.89 (0.55-1.43)
Quartile 2 (9-18) 0.69 (0.59-0.81) 0.70 (0.59-0.84) 0.63 (0.36-1.11)
Quartile 1 (1-8) 0.73 (0.60-0.89) 0.72 (0.58-0.89) 0.89 (0.50-1.59)
αThe logistic regression model was additionally adjusted for age, SEER registry, urban/rural status of the women, cancer stage, and comorbidity score. OR = Odds
Ratio CI = Confidence Interval.
βWomen of color includes African American, Hispanic, Asian, Native American and Other.
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into the model. The characteristics of facility rurality
and not being a member of a cooperative oncology
group were strongly associated with non-receipt of re-
construction overall and similar results were found
among Caucasian women and women of color (Table 4).
Breast cancer surgery volume was not found to be statis-
tically significant among the women of color (p = 0.41).
Discussion
This study explicitly examined the joint effect of race/
ethnicity and place of service on receipt of breast recon-
struction. We found significant associations between re-
ceipt of breast reconstruction following mastectomy and
race/ethnicity and place of service; with women of color
and those at rural facilities, those with lower breast can-
cer surgery volume, not a cooperative oncology group
member and non-teaching hospitals, less likely to receive
reconstruction. We did not find an interaction between
race/ethnicity and place of service on likelihood of re-
construction, suggesting that racial disparities persist
despite place of service. We found some evidence of dif-
ferential use of facility types for mastectomy by race/eth-
nicity, particularly higher proportions of women of color
attending facilities that were not members of cooperative
oncology groups, and with lower overall breast cancer
surgery volumes. More women of color were in the
lower area-level income strata than Caucasian, although
in adjusted models, women of color were over half as
likely to receive breast reconstruction as Caucasian. Sig-
nificant regional variation based on SEER registry was
also noted for breast reconstruction.
Our results add to the growing evidence around dis-
parities in use of breast reconstruction following mastec-
tomy. The procedure has state and federally-mandated
coverage due to its documented benefits to quality of
life, body image, self-esteem, and sexuality, (Albornoz
et al. 2013) yet is disproportionately under-utilized by
women of color and by some types of facilities. Several
studies have shown similar decreased use of breast re-
construction for women of color (Alderman et al. 2006;
Jagsi et al. 2014; Alderman et al. 2009; Alderman et al.
2003; Kruper et al. 2011a; Kruper et al. 2011b; Yang
et al. 2013; Sisco et al. 2012). Prior studies have also
demonstrated that facility characteristics have a significant
impact on use of reconstruction following mastectomy, in-
cluding: a) academic or teaching hospital; (Sisco et al.
2012; Reuben et al. 2009) b) urban hospital; (Reuben
et al. 2009) and c) hospital volume and size (Hershman
et al. 2012). Interestingly, in a study conducted in the
National Comprehensive Cancer Network, race/ethni-
city was not a significant determinant of breast recon-
struction, (Christian et al. 2006) unlike the work presented
here, in which racial/ethnic disparities persisted after con-
trolling for facility characteristics.
α
The logistic regression model was additionally adjusted for age, race, urban/rural status of the women, cancer 
stage, comorbidity score and facility characteristics including urban/rural, teaching hospital, NCI Cancer  
Center, cooperative oncology group member, and disproportionate share hospital.  OR= Odds Ratio CI= 
Confidence Interval.
Figure 1 Reconstruction odds ratios (OR)α and 95% CI by SEER Registry, 2005-2009.
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The idea that racial/ethnic disparities in healthcare
utilization and outcomes are at least partially explained by
place of service is not novel. The Institute of Medicine
(IOM) reviewed a large number of studies, both cancer
and non-cancer related, and reported that racial/ethnic
disparities remain, but are diminished, when accounting
for some health care system attributes that influence ac-
cess to and quality of care (Nelson 2002). Other work
points to the influence of geographic location – and hence
access to specific facilities and services – as an explanatory
factor for some racial disparities in health care utilization
(Baicker et al. 2005; Chandra et al. 2013; Skinner et al.
2003). The roles of location and facility characteristics in
health care disparities are still not well understood, and
even less so for cancer care specifically.
Because cancer care can be highly specialized, under-
standing facility characteristics that are associated with
receipt of recommended and high-quality care is par-
ticularly important to either help replicate best practices
in other facilities, or establish referral networks that fa-
cilitate equitable access. Several studies focused on cancer
care have linked facility characteristics to recommended
utilization and/or better outcomes, including higher vol-
umes, teaching or academic medical centers, NCI Can-
cer Centers, and subspecialist providers. Some of this
work further demonstrated that racial disparities in
cancer outcomes (mortality) diminished when evaluat-
ing the effect of race within similar facilities (Onega
et al. 2010). This suggests that reducing disparities in
outcomes for cancer patients of all races/ethnicities will
require a focus on improving access to high-quality
cancer care.
Several limitations of this study should be noted. First,
breast reconstruction is an elective procedure, which
some women may not choose. Important factors that
were not measured are likely to play a role, such as pa-
tient preference, cultural attitudes, and individual finan-
cial resources. Also, we used SEER-Medicare data, thus
limiting our sample to women over age 65. We were also
limited in sample size so were unable to analyze His-
panic, Asian, and Native American women separately. Fi-
nally, all women in the cohort had Medicare, so we could
not observe the effect of insurance on reconstruction.
Understanding the components that create racial dis-
parities in cancer care is vital to better redressing the
problem. The evidence is beginning to move beyond
simply identifying disparities, towards explaining them.
One model of cancer disparities recognizes the role of
factors along a hierarchical spectrum: biological/geno-
typic – individual – health care system – social/neigh-
borhood. Such a complex, multilevel model provides an
important framework, and ultimately should be eluci-
dated. This research sought to isolate the contribution
of individual-level and health care system level factors
on significantly lower use of breast reconstruction
among cancer patients of color. The effects of place of
service on breast reconstruction are significant, but simi-
lar for all women regardless of race/ethnicity. However,
even when accounting for place of service, racial/ethnic
disparities in breast reconstruction persist. Understand-
ing which factors contribute to those disparities – and
whether they are economic, cultural, behavioral, etc., is
important in order to unravel the complexities of racial/
ethnic disparities, and begin to identify the target for
interventions.
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